Search

Your search keyword '"Cosio, Borja G."' showing total 355 results

Search Constraints

Start Over You searched for: Author "Cosio, Borja G." Remove constraint Author: "Cosio, Borja G."
355 results on '"Cosio, Borja G."'

Search Results

1. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

2. International Variation in Severe Exacerbation Rates in Patients With Severe Asthma

3. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

4. Lung-function trajectories: relevance and implementation in clinical practice

5. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

6. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma

8. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

9. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

10. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study

12. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

14. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

18. AERIFY-1/-2: 2 phase 3 randomised controlled trials of itepekimab in former smokers with moderate-to-severe COPD

19. Lung-function trajectories: relevance and implementation in clinical practice

20. Is Inhaler Technique Adequately Assessed and Reported in Clinical Trials of Asthma and Chronic Obstructive Pulmonary Disease Therapy? A Systematic Review and Suggested Best Practice Checklist

21. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

31. Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”

34. Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score

35. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

39. International Severe Asthma Registry: Mission Statement

40. Determinants and Differences in Satisfaction with the Inhaler Among Patients with Asthma or COPD

41. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

42. Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma

45. Determinants of the Appearance and Progression of Early-Onset Chronic Obstructive Pulmonary Disease in Young Adults. A Case–Control Study With Follow-Up

46. EARLY COPD: determinantes de la aparición y progresión de la enfermedad pulmonar obstructiva crónica en adultos jóvenes. Protocolo de un estudio caso-control con seguimiento

47. Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study

48. The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease

49. Proyecto de biomarcadores y perfiles clínicos personalizados en la enfermedad pulmonar obstructiva crónica (proyecto BIOMEPOC)

Catalog

Books, media, physical & digital resources